These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23994871)

  • 1. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
    Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New testosterone derivatives as semi-synthetic anticancer agents against prostate cancer: synthesis and preliminary biological evaluation.
    Morin N; Bruneau J; Fortin S; Brasseur K; Leblanc V; Asselin E; Berube G
    Med Chem; 2015; 11(6):531-9. PubMed ID: 25675439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer.
    Bastien D; Hanna R; Leblanc V; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Jun; 64():442-7. PubMed ID: 23665800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities.
    Neves AP; da Silva GB; Vargas MD; Pinheiro CB; Visentin Ldo C; Filho JD; Araújo AJ; Costa-Lotufo LV; Pessoa C; de Moraes MO
    Dalton Trans; 2010 Nov; 39(42):10203-16. PubMed ID: 20871881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: comparative molecular modeling study of three distinct families of hybrids.
    Provencher-Mandeville J; Debnath C; Mandal SK; Leblanc V; Parent S; Asselin E; Bérubé G
    Steroids; 2011 Jan; 76(1-2):94-103. PubMed ID: 20869376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niphatenones, glycerol ethers from the sponge Niphates digitalis block androgen receptor transcriptional activity in prostate cancer cells: structure elucidation, synthesis, and biological activity.
    Meimetis LG; Williams DE; Mawji NR; Banuelos CA; Lal AA; Park JJ; Tien AH; Fernandez JG; de Voogd NJ; Sadar MD; Andersen RJ
    J Med Chem; 2012 Jan; 55(1):503-14. PubMed ID: 22148427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(II) complexes containing aminophosphonate esters: Synthesis, characterization, cytotoxicity and action mechanism.
    Huang KB; Chen ZF; Liu YC; Li ZQ; Wei JH; Wang M; Xie XL; Liang H
    Eur J Med Chem; 2013 Jun; 64():554-61. PubMed ID: 23685573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
    Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
    Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
    J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.
    Wang L; Gou S; Chen Y; Liu Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3417-22. PubMed ID: 15953727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of phenylene bridged binuclear bis(imino-quinolyl)palladium(II) and platinum(II) complexes.
    Motswainyana WM; Onani MO; Madiehe AM; Saibu M
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1692-4. PubMed ID: 24636106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents.
    Cincinelli R; Musso L; Dallavalle S; Artali R; Tinelli S; Colangelo D; Zunino F; De Cesare M; Beretta GL; Zaffaroni N
    Eur J Med Chem; 2013 May; 63():387-400. PubMed ID: 23517728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.
    Yin R; Gou S; Sun Y; Liu X
    Bioorg Med Chem; 2012 Feb; 20(4):1461-7. PubMed ID: 22264764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
    Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
    Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Vrzal R; Starha P; Dvorák Z; Trávnícek Z
    J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
    Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
    Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.